Equity Overview
Price & Market Data
Price: $2.05
Daily Change: -$0.08 / 3.90%
Daily Range: $1.92 - $2.26
Market Cap: $115,011,472
Daily Volume: 81,185
Performance Metrics
1 Week: 2.48%
1 Month: 90.15%
3 Months: 158.8%
6 Months: 97.14%
1 Year: 99.04%
YTD: 50.00%
Company Details
Employees: 62
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.